BioCentury
ARTICLE | Clinical News

Sirona Biochem preclinical data

March 5, 2012 8:00 AM UTC

In obese diabetic rats, SBM-TFC-039 reduced blood glucose levels at 6 hours post-treatment to the levels observed in lean control rats. In normal rats, SBM-TFC-039 reduced blood glucose excursions fol...